Previous evidence has shown that DNMT1 is overexpressed in breast cancer (Wang et al., 2018), thyroid cancer cells (Zhang et al., 2018), and pancreatic cancer (Peng et al., 2005). Here, DNMT1 is linked to thyroid cancer.